Related Experiment Video
Updated: Aug 11, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies
Rahul Mehra1, Paul Ziegler, Jodi Koehler
1Medtronic Inc., 7000 Central Avenue NE, Minneapolis, MN 55432, USA. rahul.mehra@medtronic.com
Insights
Implantable devices track atrial tachyarrhythmia (AT) burden and frequency. Changes in these rhythm control measures weakly correlate with cardiac hospitalizations in pacemaker patients with AT history.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Device Technology
Background:
- Implantable devices collect vital physiologic data for rhythm and rate control.
- Current guidelines lack quantitative definitions for rhythm and rate control.
- Atrial tachyarrhythmias (AT) significantly impact patient outcomes.
Purpose of the Study:
- To assess the relationship between changes in rhythm/rate control parameters and clinical outcomes in AT patients.
- To define quantitative measures for rhythm control (AT burden, episode frequency) and rate control (ventricular rate >120 bpm, median rate during AT).
- To evaluate correlations between these parameter changes and cardiac hospitalizations, SF-36, and symptom checklist scores.
Main Methods:
- Analysis of data from 643 patients with AT history and bradycardia receiving pacemakers.
- Collection of rhythm and rate control data at 1, 4, and 7 months post-implant.
- Correlation analysis between changes in AT burden/frequency and cardiac hospitalization rates, SF-36, and symptom scores.
Main Results:
- A weak but significant positive correlation was found between changes in AT burden/frequency and cardiac hospitalization rates (P = 0.01, r = 0.08).
- No significant correlation was observed between rhythm/rate control measures and SF-36 or symptom checklist scores.
- The asymptomatic nature of AT in this cohort may explain the lack of correlation with quality-of-life measures.
Conclusions:
- Implantable device data provide a valuable tool for monitoring rhythm and rate control in AT patients.
- In pacemaker patients with AT history, improved rhythm control shows a weak correlation with reduced cardiac hospitalizations.
- Further research is needed to understand the impact of asymptomatic AT on clinical outcomes and quality of life.
Abstract:
Implantable devices can store significant information about physiologic parameters relating to rhythm and rate control. The primary objective of our analysis was to evaluate the relationship between changes in these parameters and changes in clinical outcomes in patients with atrial tachyarrhythmias (AT). Because the present guidelines do not provide quantitative definition of rhythm and rate control, we used the percent of time in AT and frequency of such episodes as measures of rhythm control. Rate control was measured as the percent of time spent at a ventricular rate >120 beats/min, as well as the median ventricular rate during AT. Analysis was conducted in 643 patients with a history of AT and bradycardia receiving pacemakers to evaluate whether changes in these parameters were correlated with changes in cardiac hospitalization rates and SF-36 and symptom checklist scores. All patients were followed at 1, 4, and 7 months postimplant, during which rhythm and rate control data were collected. Positive correlation was observed between changes in cardiac hospitalization rate and changes in AT burden, as well as frequency of AT (P = 0.01, r = 0.08 for each). Changes in SF-36 or symptom checklist scores did not correlate with changes in rhythm and rate control measures. This patient cohort had relatively asymptomatic atrial fibrillation (symptom checklist frequency and severity scores of 14.3 +/- 9.5 and 11.5 +/- 7.9, respectively), and this may have contributed to the lack of correlation with SF-36 and symptom scores. Data stored in implantable devices offer a unique opportunity to monitor parameters of rhythm as well as rate control in patients with AT. In patients implanted with pacemakers for management of bradyarrhythmias who have a history of AT, a significantly positive but weak correlation was observed between changes in rhythm control measures (AT burden and frequency) and changes in cardiac hospitalization rate.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

